Ascendis Pharma A/S (ASND)
232.21
+6.96
(+3.09%)
USD |
NASDAQ |
Oct 19, 14:45
Ascendis Pharma Cash from Operations (Annual) : 60.83M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 60.83M |
| December 31, 2024 | -331.21M |
| December 31, 2023 | -505.27M |
| December 31, 2022 | -520.97M |
| December 31, 2021 | -493.65M |
| December 31, 2020 | -309.56M |
| December 31, 2019 | -196.92M |
| Date | Value |
|---|---|
| December 31, 2018 | -163.75M |
| December 31, 2017 | -107.27M |
| December 31, 2016 | -66.57M |
| December 31, 2015 | -48.20M |
| December 31, 2014 | -24.41M |
| December 31, 2013 | 8.377M |
| December 31, 2012 | -0.8375M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| BioMarin Pharmaceutical, Inc. | 827.99M |
| Novo Nordisk A/S | 18.01B |
| Evaxion AS | -6.645M |
| Genmab A/S | 1.190B |
| Zealand Pharma A/S | 987.74M |